MetLife Investment Management’s ADC Therapeutics ADCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$121K	Sell	45,027 -460	-1%	-$1.23K	﹤0.01%	2449
2025 Q1	$64.1K	Buy	45,487 +14,370	+46%	+$20.3K	﹤0.01%	2663
2024 Q4	$61.9K	Sell	31,117 -11,972	-28%	-$23.8K	﹤0.01%	2721
2024 Q3	$136K	Buy	43,089 +24,279	+129%	+$76.5K	﹤0.01%	2486
2024 Q2	$59.4K	Buy	+18,810	New	+$59.4K	﹤0.01%	2732